Microsoft India and SRL Diagnostics have partnered to expand the artificial intelligence (AI) network for healthcare to pathology. This collaboration will help improve the quality of digital pathology for population screening by bringing together Microsoft’s Azure and AI innovations along with SRL’S expertise in the study of cells and tissues (histology).
Digital pathology is increasingly being preferred as it has helped bring improvement in service delivery, patient safety and communications while reducing errors and lowering costs. Histopathology is a specialized form of pathology for analysing tissue biopsies (mounted on glass slides) and is used for detecting numerous diseases. Growing prevalence of chronic diseases such as cancer is one of the key factors for the need for pathology to transform.
“Microsoft is committed to empower both the healthcare industry and patients by using AI to democratise healthcare for all. Our partnership with SRL Diagnostics will assist pathologists by equipping them with technology that will augment their capability, “said Mr. Anil Bhansali, Managing Director, Microsoft India (R&D) Pvt Ltd.
By increasing efficiency in the initial steps in a biopsy tissue analysis through artificial neural networks, it will be possible for a histopathology laboratory to cut down on inadvertent manual errors and process more samples in a day with higher level of accuracy.
Mr. Arindam Haldar, Chief Executive Officer at SRL Diagnostics said “Diagnosis is the first step to disease management. Without accurate identification of the cause, there is no possibility of a precise treatment. With the growing number of samples of cancer, as well as of other diseases, there’s a need to quickly and accurately analyse the samples to help doctors arrive at a diagnosis faster”.
The “AI Network for Healthcare” aims to maximise the ability of AI and cloud computing to accelerate innovation in the healthcare industry and improve the lives of people around the world.
(Image Courtesy : www.pinterest.com)